ID   EPHAA_HUMAN             Reviewed;        1008 AA.
AC   Q5JZY3; A4FU89; J3KPB5; Q6NW42;
DT   27-SEP-2005, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2013, sequence version 2.
DT   12-OCT-2022, entry version 166.
DE   RecName: Full=Ephrin type-A receptor 10;
DE            EC=2.7.10.1;
DE   Flags: Precursor;
GN   Name=EPHA10;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2),
RP   ALTERNATIVE SPLICING, FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=15777695; DOI=10.1016/j.bbagen.2005.01.011;
RA   Aasheim H.-C., Patzke S., Hjorthaug H.S., Finne E.F.;
RT   "Characterization of a novel Eph receptor tyrosine kinase, EphA10,
RT   expressed in testis.";
RL   Biochim. Biophys. Acta 1723:1-7(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 501-1008 (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   VARIANTS [LARGE SCALE ANALYSIS] HIS-150; LYS-220; ILE-281; PRO-630; ARG-775
RP   AND THR-956.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Receptor for members of the ephrin-A family. Binds to EFNA3,
CC       EFNA4 and EFNA5. {ECO:0000269|PubMed:15777695}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.1;
CC   -!- INTERACTION:
CC       Q5JZY3-3; Q8N9N5: BANP; NbExp=3; IntAct=EBI-10244652, EBI-744695;
CC       Q5JZY3-3; Q13557: CAMK2D; NbExp=3; IntAct=EBI-10244652, EBI-351018;
CC       Q5JZY3-3; Q13643: FHL3; NbExp=3; IntAct=EBI-10244652, EBI-741101;
CC       Q5JZY3-3; Q12800: TFCP2; NbExp=3; IntAct=EBI-10244652, EBI-717422;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Cell membrane {ECO:0000305}; Single-
CC       pass type I membrane protein {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Cell membrane {ECO:0000305}; Single-
CC       pass type I membrane protein {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Secreted {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q5JZY3-1; Sequence=Displayed;
CC       Name=2; Synonyms=Epha10s;
CC         IsoId=Q5JZY3-2; Sequence=VSP_015772, VSP_015773;
CC       Name=3; Synonyms=Epha10*;
CC         IsoId=Q5JZY3-3; Sequence=VSP_015774, VSP_015775;
CC   -!- TISSUE SPECIFICITY: Mainly expressed in testis.
CC       {ECO:0000269|PubMed:15777695}.
CC   -!- DOMAIN: The protein kinase domain is predicted to be catalytically
CC       inactive.
CC   -!- MISCELLANEOUS: [Isoform 3]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Ephrin receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI12934.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ872185; CAI43321.1; -; Genomic_DNA.
DR   EMBL; AJ781169; CAG77605.1; -; mRNA.
DR   EMBL; AC104336; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC067734; AAH67734.1; -; mRNA.
DR   EMBL; BC112933; AAI12934.1; ALT_INIT; mRNA.
DR   CCDS; CCDS41305.1; -. [Q5JZY3-1]
DR   CCDS; CCDS425.1; -. [Q5JZY3-2]
DR   RefSeq; NP_001092909.1; NM_001099439.1. [Q5JZY3-1]
DR   RefSeq; NP_775912.2; NM_173641.2. [Q5JZY3-2]
DR   AlphaFoldDB; Q5JZY3; -.
DR   SMR; Q5JZY3; -.
DR   BioGRID; 129927; 5.
DR   IntAct; Q5JZY3; 84.
DR   STRING; 9606.ENSP00000362139; -.
DR   ChEMBL; CHEMBL2363043; -.
DR   GlyGen; Q5JZY3; 2 sites.
DR   iPTMnet; Q5JZY3; -.
DR   PhosphoSitePlus; Q5JZY3; -.
DR   BioMuta; EPHA10; -.
DR   DMDM; 476007830; -.
DR   jPOST; Q5JZY3; -.
DR   MassIVE; Q5JZY3; -.
DR   PaxDb; Q5JZY3; -.
DR   PeptideAtlas; Q5JZY3; -.
DR   PRIDE; Q5JZY3; -.
DR   ProteomicsDB; 63538; -. [Q5JZY3-1]
DR   ProteomicsDB; 63539; -. [Q5JZY3-2]
DR   ProteomicsDB; 63540; -. [Q5JZY3-3]
DR   Antibodypedia; 51311; 279 antibodies from 30 providers.
DR   DNASU; 284656; -.
DR   Ensembl; ENST00000319637.6; ENSP00000316395.6; ENSG00000183317.17. [Q5JZY3-2]
DR   Ensembl; ENST00000373048.9; ENSP00000362139.4; ENSG00000183317.17. [Q5JZY3-1]
DR   GeneID; 284656; -.
DR   KEGG; hsa:284656; -.
DR   MANE-Select; ENST00000373048.9; ENSP00000362139.4; NM_001099439.2; NP_001092909.1.
DR   UCSC; uc001cbw.5; human. [Q5JZY3-1]
DR   CTD; 284656; -.
DR   DisGeNET; 284656; -.
DR   GeneCards; EPHA10; -.
DR   HGNC; HGNC:19987; EPHA10.
DR   HPA; ENSG00000183317; Tissue enhanced (brain, intestine, testis).
DR   MIM; 611123; gene.
DR   neXtProt; NX_Q5JZY3; -.
DR   OpenTargets; ENSG00000183317; -.
DR   PharmGKB; PA134938798; -.
DR   VEuPathDB; HostDB:ENSG00000183317; -.
DR   eggNOG; KOG0196; Eukaryota.
DR   GeneTree; ENSGT00940000160752; -.
DR   HOGENOM; CLU_000288_141_4_1; -.
DR   InParanoid; Q5JZY3; -.
DR   OMA; FGCLQLP; -.
DR   TreeFam; TF314013; -.
DR   PathwayCommons; Q5JZY3; -.
DR   Reactome; R-HSA-2682334; EPH-Ephrin signaling.
DR   Reactome; R-HSA-3928663; EPHA-mediated growth cone collapse.
DR   Reactome; R-HSA-3928665; EPH-ephrin mediated repulsion of cells.
DR   SignaLink; Q5JZY3; -.
DR   BioGRID-ORCS; 284656; 11 hits in 1109 CRISPR screens.
DR   ChiTaRS; EPHA10; human.
DR   GeneWiki; EPHA10; -.
DR   GenomeRNAi; 284656; -.
DR   Pharos; Q5JZY3; Tbio.
DR   PRO; PR:Q5JZY3; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q5JZY3; protein.
DR   Bgee; ENSG00000183317; Expressed in sperm and 127 other tissues.
DR   ExpressionAtlas; Q5JZY3; baseline and differential.
DR   Genevisible; Q5JZY3; HS.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0043235; C:receptor complex; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0005005; F:transmembrane-ephrin receptor activity; IDA:UniProtKB.
DR   GO; GO:0007411; P:axon guidance; IBA:GO_Central.
DR   GO; GO:0033674; P:positive regulation of kinase activity; IBA:GO_Central.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IBA:GO_Central.
DR   CDD; cd00063; FN3; 2.
DR   Gene3D; 1.10.150.50; -; 1.
DR   Gene3D; 2.60.40.10; -; 2.
DR   InterPro; IPR027936; Eph_TM.
DR   InterPro; IPR001090; Ephrin_rcpt_lig-bd_dom.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR008979; Galactose-bd-like_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR016257; Tyr_kinase_ephrin_rcpt.
DR   InterPro; IPR001426; Tyr_kinase_rcpt_V_CS.
DR   Pfam; PF14575; EphA2_TM; 1.
DR   Pfam; PF01404; Ephrin_lbd; 1.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   Pfam; PF00536; SAM_1; 1.
DR   PIRSF; PIRSF000666; TyrPK_ephrin_receptor; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00615; EPH_lbd; 1.
DR   SMART; SM00060; FN3; 2.
DR   SMART; SM00454; SAM; 1.
DR   SUPFAM; SSF47769; SSF47769; 1.
DR   SUPFAM; SSF49265; SSF49265; 1.
DR   SUPFAM; SSF49785; SSF49785; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS51550; EPH_LBD; 1.
DR   PROSITE; PS50853; FN3; 2.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00790; RECEPTOR_TYR_KIN_V_1; 1.
DR   PROSITE; PS00791; RECEPTOR_TYR_KIN_V_2; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell membrane; Glycoprotein; Kinase;
KW   Membrane; Nucleotide-binding; Receptor; Reference proteome; Repeat;
KW   Secreted; Signal; Transferase; Transmembrane; Transmembrane helix;
KW   Tyrosine-protein kinase.
FT   SIGNAL          1..33
FT                   /evidence="ECO:0000255"
FT   CHAIN           34..1008
FT                   /note="Ephrin type-A receptor 10"
FT                   /id="PRO_0000042157"
FT   TOPO_DOM        34..565
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        566..586
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        587..1008
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          35..216
FT                   /note="Eph LBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00883"
FT   DOMAIN          340..452
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          456..554
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          645..900
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          933..997
FT                   /note="SAM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00184"
FT   REGION          322..342
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        311
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        486
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         284..295
FT                   /note="ACPPGFYKVSPR -> GIQLAGGRGVGV (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:15777695"
FT                   /id="VSP_015772"
FT   VAR_SEQ         296..1008
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:15777695"
FT                   /id="VSP_015773"
FT   VAR_SEQ         889..892
FT                   /note="ERPR -> LPPH (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_015774"
FT   VAR_SEQ         893..1008
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_015775"
FT   VARIANT         103
FT                   /note="V -> L (in dbSNP:rs34557762)"
FT                   /id="VAR_055992"
FT   VARIANT         150
FT                   /note="R -> H (in a gastric adenocarcinoma sample; somatic
FT                   mutation; dbSNP:rs771803475)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042159"
FT   VARIANT         220
FT                   /note="T -> K (in dbSNP:rs56276182)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042160"
FT   VARIANT         281
FT                   /note="F -> I (in dbSNP:rs4653328)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042161"
FT   VARIANT         629
FT                   /note="L -> P (in dbSNP:rs17511304)"
FT                   /id="VAR_055993"
FT   VARIANT         630
FT                   /note="L -> P"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042162"
FT   VARIANT         645
FT                   /note="V -> I (in dbSNP:rs12405650)"
FT                   /id="VAR_055994"
FT   VARIANT         749
FT                   /note="G -> E (in dbSNP:rs6671088)"
FT                   /id="VAR_055995"
FT   VARIANT         775
FT                   /note="H -> R (in a breast infiltrating ductal carcinoma
FT                   sample; somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042163"
FT   VARIANT         807
FT                   /note="R -> Q (in dbSNP:rs6670599)"
FT                   /id="VAR_055996"
FT   VARIANT         956
FT                   /note="A -> T"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042164"
FT   CONFLICT        458
FT                   /note="D -> G (in Ref. 1; CAI43321)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        503
FT                   /note="T -> A (in Ref. 1; CAI43321)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1008 AA;  109716 MW;  82D60740B7B6B9BD CRC64;
     METCAGPHPL RLFLCRMQLC LALLLGPWRP GTAEEVILLD SKASQAELGW TALPSNGWEE
     ISGVDEHDRP IRTYQVCNVL EPNQDNWLQT GWISRGRGQR IFVELQFTLR DCSSIPGAAG
     TCKETFNVYY LETEADLGRG RPRLGGSRPR KIDTIAADES FTQGDLGERK MKLNTEVREI
     GPLSRRGFHL AFQDVGACVA LVSVRVYYKQ CRATVRGLAT FPATAAESAF STLVEVAGTC
     VAHSEGEPGS PPRMHCGADG EWLVPVGRCS CSAGFQERGD FCEACPPGFY KVSPRRPLCS
     PCPEHSRALE NASTFCVCQD SYARSPTDPP SASCTRPPSA PRDLQYSLSR SPLVLRLRWL
     PPADSGGRSD VTYSLLCLRC GREGPAGACE PCGPRVAFLP RQAGLRERAA TLLHLRPGAR
     YTVRVAALNG VSGPAAAAGT TYAQVTVSTG PGAPWEEDEI RRDRVEPQSV SLSWREPIPA
     GAPGANDTEY EIRYYEKGQS EQTYSMVKTG APTVTVTNLK PATRYVFQIR AASPGPSWEA
     QSFNPSIEVQ TLGEAASGSR DQSPAIVVTV VTISALLVLG SVMSVLAIWR RPCSYGKGGG
     DAHDEEELYF HFKVPTRRTF LDPQSCGDLL QAVHLFAKEL DAKSVTLERS LGGGRFGELC
     CGCLQLPGRQ ELLVAVHMLR DSASDSQRLG FLAEALTLGQ FDHSHIVRLE GVVTRGSTLM
     IVTEYMSHGA LDGFLRRHEG QLVAGQLMGL LPGLASAMKY LSEMGYVHRG LAARHVLVSS
     DLVCKISGFG RGPRDRSEAV YTTMSGRSPA LWAAPETLQF GHFSSASDVW SFGIIMWEVM
     AFGERPYWDM SGQDVIKAVE DGFRLPPPRN CPNLLHRLML DCWQKDPGER PRFSQIHSIL
     SKMVQDPEPP KCALTTCPRP PTPLADRAFS TFPSFGSVGA WLEALDLCRY KDSFAAAGYG
     SLEAVAEMTA QDLVSLGISL AEHREALLSG ISALQARVLQ LQGQGVQV
//
